Skip to main content
SpringerLink
Log in

1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Previous literature suggests that the anorexic action of peripherally administered serotonin (5-HT) is mediated by 5-HT2 receptors. This study, therefore, examined the effect of DOI, a non-indole 5-HT2 agonist, on deprivation-induced feeding. Rats were first adapted to a schedule in which a milk diet was presented for 6 h daily. Intraperitoneal (IP) administration of DOI (1.0–11.2 μmol/kg) inhibited feeding in a dose-related fashion (ID50=2.6 μmol/kg). One hour pretreatment with 6.0 μmol/kg of the 5-HT2 antagonists ketanserin and LY53857 completely reversed the anorexic action of an equimolar dose of DOI. Neither ketanserin nor LY53857, alone, altered baseline feeding. Further testing demonstrated the antagonistic effect of LY53857 (0.047–6.0 μmol/kg, IP) to be dose related, with an ID50 of 0.14 μmol/kg. Ten minute pretreatment with 1-(1-naphthyl)-piperazine (1-NP; 2.0 or 4.0 μmol/kg), a mixed-acting agent with 5HT2 blocking actions, also attenuated the anorexic effect of 6.0 μmol/kg DOI. Unlike ketanserin and LY53857, however, 1-NP did reduce food intake by itself. By contrast with ketanserin, LY53857 and 1-NP, the peripherally-acting 5-HT2 antagonist xylamidine failed to alter the anorexic effect of DOI. Taken together, these results suggest that central 5-HT2 receptors are important in the control of ingestive behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bendotti C, Samanin R (1987) The role of putative 5-HT1a and 5-HT1b receptors in the control of feeding in rats. Life Sci 41:635–642

    Google Scholar 

  • Berken GH, Weinstein DO, Stern WC (1984) Weight gain — a side effect of tricyclic antidepressants. J Affective Disord 7:133–138

    Google Scholar 

  • Blackshear MA, Sanders-Bush E (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther 221:303–308

    Google Scholar 

  • Blundell JE (1977) Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1:15–42

    Google Scholar 

  • Clineschmidt BV, McGuffin JC, Pflueger AB, Totaro JA (1978) A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-{1-piperazinyl}-pyrazine (MK-212). Br J Pharmacol 62:579–589

    Google Scholar 

  • Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL (1985) Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235(3):696–708

    Google Scholar 

  • Cohen ML, Fuller RW, Kurz KD (1983a) Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats. Hypertension 5(5):676–681

    Google Scholar 

  • Cohen ML, Fuller RW, Kurz KD (1983b) LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J Pharmacol Exp Ther 227(2):327–332

    Google Scholar 

  • Cohen ML, Colbert W, Wittenauer LA (1985a) Receptor specificity of the 5-HT2 receptor antagonist, LY53857. Drug Dev Res 4:313–321

    Google Scholar 

  • Cohen ML, Schenck KW, Colbert W, Wittenauer L (1985b) Role of 5-HT2 receptors in serotonin-induced contractions of non-vascular smooth muscle. J Pharmacol Exp Ther 232(3):770–774

    Google Scholar 

  • Copp FC, Green AF, Hodson HF, Randall AW, Sim MF (1967) New peripheral antagonists of 5-hydroxytryptamine. Nature 214:200–201

    Google Scholar 

  • Dourish CT, Hutson PH, Kennett GA, Curzon G (1986) 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite [Suppl] 7:127–140

    Google Scholar 

  • Dwoskin LP, Sparber SB (1983) Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant. J Pharmacol Exp Ther 225(1):77–84

    Google Scholar 

  • Fletcher PJ, Burton MJ (1986) Dissociation of the anorectic actions of 5-HTP and fenfluramine. Psychopharmacology 89:216–220

    Google Scholar 

  • Fuller RW, Snoddy HD, Mason NR, Hemrick-Luecke SK, Clemens JA (1981) Substituted piperazines as central serotonin agonists: Comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. J Pharmacol Exp Ther 218(3):636–641

    Google Scholar 

  • Fuller RW, Kurz KD, Mason NR, Cohen ML (1986) Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol 125:71–77

    Google Scholar 

  • Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39:825–830

    Google Scholar 

  • Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505–2511

    Google Scholar 

  • Glennon RA, Slusher RM, Lyon RA, Titeler M, McKenney JD (1986) 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues. J Med Chem 29:2375–2380

    Google Scholar 

  • Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25(12):1307–1313

    Google Scholar 

  • Harris B, Harper M (1980) Unusual appetites in patients on mianserin. Lancet I (8168):590

    Google Scholar 

  • Henck JW, Rezabek DH, Rech RH (1985) Comparison of anorexia and motor disruption by cyclazocine and quipazine. Pharmacol Biochem Behav 22:671–676

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I] iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Kirk RE (1982) Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont, CA

    Google Scholar 

  • Leysen JE, Tollenaere JP (1982) Biochemical models for serotonin receptors. Annu Rep Med Chem 17:1–10

    Google Scholar 

  • Leysen JE, Niemeyeers CJE, Tollenaere JP, Laduron PM (1982) [3H]-ketanserin (R41468), a selective 3H-ligand for serotonin2 receptor binding sites. Mol Pharmacol 21:301–314

    Google Scholar 

  • Leibowitz SF, Shor-Posner G (1986) Brain serotonin and eating behavior. Appetite [Suppl] 7:1–14

    Google Scholar 

  • Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in rat. J Pharmacol Exp Ther 228(3):133–139

    Google Scholar 

  • Massi M, Marini S (1987) Effect of the 5-HT2 antagonist ritanserin on food intake and on 5-HT induced anorexia in the rat. Pharmacol Biochem Behav 26:333–340

    Google Scholar 

  • Mawson C, Whittington H (1970) Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol 39:223P

    Google Scholar 

  • Mokler DJ, Commissaris RL, Warner MR, Rech RH (1983) Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamin, quipazine and lisuride by 5-hydroxytryptamine antagonists. J Pharmacol Exp Ther 227(3):557–562

    Google Scholar 

  • Mokler DJ, Stoudt KW, Rech RH (1985) The 5-HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs. Pharmacol Biochem Behav 22:677–682

    Google Scholar 

  • Nobrega JN, Coscina DV (1987) Effects on chronic amitriptyline and desipramine on food intake and body weight in rats. Pharmacol Biochem Behav 27:105–112

    Google Scholar 

  • Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529–540

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol labelled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • Rech RH, Commissaris RL (1982) Neurotransmitter basis of the behavioral effects of hallucinogens. Neurosci Biobehav Rev 6:521–527

    Google Scholar 

  • Samanin R, Bendotti C, Candelaresi G, Garattini S (1977) Specificity of serotonergic involvement in the decrease of food intake induced by quipazine in the rat. Life Sci 21:1259–1266

    Google Scholar 

  • Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163

    Google Scholar 

  • Shannon M, Battaglia G, Glennon RA, Titeler M (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol 102:23–29

    Google Scholar 

  • Simansky KJ, Schechter LE (1987) Dissociation of behavioral properties of 1-arylpiperazines in models for central serotonergic stimulation in rodents. Fed Proc [Abstr] 46:966

    Google Scholar 

  • Simansky KJ, Bourbonais KA, Smith GP (1985) Food-related stimuli increase the ratio of 3,4-dihydroxyphenylacetic acid to dopamine in the hypothalamus. Pharmacol Biochem Behav 23:253–258

    Google Scholar 

  • Simansky KJ, Cohen BI, Eberle K (1987) Inhibition by 5-HT2 antagonists of the anorexic actions of peripherally administered 5-hydroxytryptamine (5-HT) and 4-HT in rats. Soc Neurosci [Abstr] 13:15

    Google Scholar 

  • Standridge RT, Howell HG, Gylys JA, Partyka RA (1976) Phenylalkylamines with potential psychotherapeutic utility. 1. 2-amino-1-(2,5-dimethoxy-4-methylphenyl)butane. J Med Chem 19(12):1400–1404

    Google Scholar 

  • Tallarida RJ, Murray RB (1981) Manual of pharmacologic calculations with computer programs. Springer, New York

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard JR (1985a) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur J Pharmacol 106:271–282

    Google Scholar 

  • Tricklebank MD, Forler C, Middlemiss DN, Fozard JR (1985b) Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N,N-dimethyltryptamine in the rat. Eur J Pharmacol 117:15–24

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Medical College of Pennsylvania at Eastern Pennsylvania Psychiatric Institute, 3200 Henry Avenue, 19129, Philadelphia, PA, USA

    L. E. Schechter & K. J. Simansky

Authors
  1. L. E. Schechter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. J. Simansky
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

A portion of these results were presented in a preliminary report at the Annual Meeting of the Society for Neuroscience in November 1987.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schechter, L.E., Simansky, K.J. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology 94, 342–346 (1988). https://doi.org/10.1007/BF00174687

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00174687

Key words

Search

Navigation